University of Tennessee Cancer Institute at Methodist Central Hospital — Memphis, Tennessee

University of Tennessee Cancer Institute at Methodist Central Hospital is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute at Methodist Central Hospital has participated in 8 clinical trials.

Therapeutic areas: Breast Cancer, Endometrial Cancer, Colorectal Cancer.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute at Methodist Central Hospital?

University of Tennessee Cancer Institute at Methodist Central Hospital has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute at Methodist Central Hospital conducted?

University of Tennessee Cancer Institute at Methodist Central Hospital has 8 clinical trials on record. Their work covers Breast Cancer, Endometrial Cancer, Colorectal Cancer.

Is University of Tennessee Cancer Institute at Methodist Central Hospital accredited by Crixeo Health?

Yes — University of Tennessee Cancer Institute at Methodist Central Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Tennessee Cancer Institute at Methodist Central Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.